The observed association with progressive disease (PD) and stable disease (SD) in our cohort suggests the existence of EGFR-driven melanoma subtypes, warranting further investigation into the functional consequences of EGFR activation [17, 21]. This evidence concerns the gene EGFR and melanoma.